OxCan: Funding, Investors & Team (Oct 2026)
OxCan is a startup that uses machine learning and liquid biopsy for early lung cancer detection.
OxCan has raised $1.8M across 1 funding round on record, the most recent a Seed of $1.8M announced in Sep 2021.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
OxCan Company Profile and Key Stats
Latest funding round on record: Sep 2021.
OxCan Funding Rounds
OxCan Founders and Leadership Team
No contact details are on record for this team yet.
OxCan Funding Compared to Other Biotechnology Startups
OxCan's latest round of $1.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like OxCan in Biotechnology and Oxford
Companies Similar to OxCan
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
OxCan Funding FAQs
What does OxCan do?
OxCan is a startup that uses machine learning and liquid biopsy for early lung cancer detection.
How much funding has OxCan raised?
OxCan has raised $1.8M across 1 round on record. The most recent is a Seed of $1.8M announced in Sep 2021.
When did OxCan last raise funding?
OxCan's most recent funding round on record is a Seed of $1.8M, announced in Sep 2021.
Who is the CEO of OxCan?
Peter Liu is listed as CEO at OxCan.
Where is OxCan headquartered?
OxCan is based in Oxford, Oxfordshire, United Kingdom.
How many employees does OxCan have?
OxCan is in the 1-10 employee band.
How does OxCan's funding compare to other Biotechnology startups?
OxCan's latest round of $1.8M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's OxCan Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for OxCan is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.